Home
Life Sciences

Sector: Life Sciences

Three things to know about the US government’s new strategy for standards development

Here’s the critical background to know as innovators today participate in a USPTO listening session about the intersection between standards development and IP

Unified Patent Court grants preliminary injunction to 10x Genomics

A preliminary injunction strikes a heavy blow against NanoString Technologies which already withdrew from Germany due to a previous 10x injunction and now must do so from 16 more European countries

Life Sciences correspondent

Thought leadership from industry experts

Latest updates

EPO Enlarged Board of Appeal confirms use of post-published data to support inventive step

Latest content

UPC looks set for first antitrust spat in unusual life sciences dispute

The plot continues to thicken in 10x Genomics’ multi-faceted spat with NanoString

13 July 2023

Small innovator's litigation funding enabled $106.5 million verdict against Medtronic

Colibri Heart Valve had no financial alternative to pay for the protracted legal battle and plans to invest the proceeds to further its development pathway into the US marketplace

12 July 2023

Magistrate Judge Jennifer L Hall has ‘impeccable credentials’ for Delaware judge nomination

Docket Navigator shows Hall has presided over nearly 190 patent cases as a judge and previously had patent litigation experience in private practice

10 July 2023

Moderna files Irish lawsuit against Pfizer/BioNTech in ever-expanding covid dispute

Complex web of mRNA patent litigation has now spread to Ireland

07 July 2023

How life sciences companies are embracing the UPC

Pharma, biotech and medical device companies have surprised the patent community with their dominance of early proceedings at the new court

04 July 2023

$303M award against Samsung leads Q2's top US patent jury verdicts

Jury trials in US patent cases spiked to high levels with 25 verdicts issued from April to June– and 60% of these favoured patentees, according to Docket Navigator data

03 July 2023

Enlarged Board of Appeal’s landmark ‘plausibility’ ruling creates new uncertainties

Recent EPO preliminary opinion highlights the EBA’s failure to clear up doubts concerning post-filed evidence

27 June 2023

Amgen continues to write biosimilars IP playbook with first-to-market Stelara settlement

Californian company secures pole position to launch ustekinumab variant, enjoying another biosimilar triumph

23 June 2023

BREAKING: US Senators Tillis and Coons re-file patent eligibility bill

The Patent Eligibility Restoration Act aims to repair damage from US jurisprudence that Tillis says “is undermining American innovation and allowing foreign adversaries like China to overtake us”

22 June 2023

Patent transactions in Q1 2023

Featured in Secondary Market Activity

Allied Security Trust has released its latest patent deals report which tracked 371 transactions including the sale of 68 Intel assets to Daedalus Group

21 June 2023

Unlock unlimited access to all IAM content